Justin I Odegaard

Summary

Affiliation: Stanford University
Country: USA

Publications

  1. ncbi Alternative macrophage activation and metabolism
    Justin I Odegaard
    Department of Pathology, Stanford University School of Medicine, California 94305 5103, USA
    Annu Rev Pathol 6:275-97. 2011
  2. ncbi Alternative M2 activation of Kupffer cells by PPARdelta ameliorates obesity-induced insulin resistance
    Justin I Odegaard
    Division of Endocrinology, Metabolism and Gerontology, Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305 5103, USA
    Cell Metab 7:496-507. 2008
  3. ncbi IL-4/STAT6 immune axis regulates peripheral nutrient metabolism and insulin sensitivity
    Roberto R Ricardo-Gonzalez
    Division of Endocrinology, Metabolism and Gerontology, Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA
    Proc Natl Acad Sci U S A 107:22617-22. 2010
  4. ncbi PPAR-delta senses and orchestrates clearance of apoptotic cells to promote tolerance
    Lata Mukundan
    Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA
    Nat Med 15:1266-72. 2009
  5. ncbi Quantitative expansion of ES cell-derived myeloid progenitors capable of differentiating into macrophages
    Justin I Odegaard
    Division of Endocrinology, Metabolism and Gerontology, Department of Medicine and Graduate Program in Immunology, Stanford University School of Medicine, Stanford, CA 94305 5103, USA
    J Leukoc Biol 81:711-9. 2007
  6. ncbi Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance
    Justin I Odegaard
    Division of Endocrinology, Metabolism and Gerontology, Department of Medicine, Stanford University School of Medicine, Stanford, California 94305 5103, USA
    Nature 447:1116-20. 2007
  7. ncbi Mechanisms of macrophage activation in obesity-induced insulin resistance
    Justin I Odegaard
    Graduate Program in Immunology, Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305 5103, USA
    Nat Clin Pract Endocrinol Metab 4:619-26. 2008
  8. ncbi Oxidative metabolism and PGC-1beta attenuate macrophage-mediated inflammation
    Divya Vats
    Division of Endocrinology, Metabolism and Gerontology, Department of Medicine and Graduate Program in Immunology, Stanford University School of Medicine, Stanford, California 94305, USA
    Cell Metab 4:13-24. 2006
  9. ncbi Connecting type 1 and type 2 diabetes through innate immunity
    Justin I Odegaard
    Department of Pathology, Stanford University School of Medicine, Stanford, California 94305, USA
    Cold Spring Harb Perspect Med 2:a007724. 2012

Collaborators

Detail Information

Publications9

  1. ncbi Alternative macrophage activation and metabolism
    Justin I Odegaard
    Department of Pathology, Stanford University School of Medicine, California 94305 5103, USA
    Annu Rev Pathol 6:275-97. 2011
    ..The therapeutic implications of this conclusion are profound because they suggest that pharmacologic targeting of macrophage activation, rather than simply inflammation, might be efficacious in treating this global epidemic...
  2. ncbi Alternative M2 activation of Kupffer cells by PPARdelta ameliorates obesity-induced insulin resistance
    Justin I Odegaard
    Division of Endocrinology, Metabolism and Gerontology, Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305 5103, USA
    Cell Metab 7:496-507. 2008
    ..Taken together, these data suggest an unexpected beneficial role for alternatively activated Kupffer cells in metabolic syndrome and type 2 diabetes...
  3. ncbi IL-4/STAT6 immune axis regulates peripheral nutrient metabolism and insulin sensitivity
    Roberto R Ricardo-Gonzalez
    Division of Endocrinology, Metabolism and Gerontology, Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA
    Proc Natl Acad Sci U S A 107:22617-22. 2010
    ....
  4. ncbi PPAR-delta senses and orchestrates clearance of apoptotic cells to promote tolerance
    Lata Mukundan
    Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA
    Nat Med 15:1266-72. 2009
    ..Thus, PPAR-delta has a pivotal role in orchestrating the timely disposal of apoptotic cells by macrophages, ensuring that tolerance to self is maintained...
  5. ncbi Quantitative expansion of ES cell-derived myeloid progenitors capable of differentiating into macrophages
    Justin I Odegaard
    Division of Endocrinology, Metabolism and Gerontology, Department of Medicine and Graduate Program in Immunology, Stanford University School of Medicine, Stanford, CA 94305 5103, USA
    J Leukoc Biol 81:711-9. 2007
    ....
  6. ncbi Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance
    Justin I Odegaard
    Division of Endocrinology, Metabolism and Gerontology, Department of Medicine, Stanford University School of Medicine, Stanford, California 94305 5103, USA
    Nature 447:1116-20. 2007
    ....
  7. ncbi Mechanisms of macrophage activation in obesity-induced insulin resistance
    Justin I Odegaard
    Graduate Program in Immunology, Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305 5103, USA
    Nat Clin Pract Endocrinol Metab 4:619-26. 2008
    ..The functional importance of macrophage activation is further discussed in the context of host defense to highlight the crosstalk between innate immunity and metabolism...
  8. ncbi Oxidative metabolism and PGC-1beta attenuate macrophage-mediated inflammation
    Divya Vats
    Division of Endocrinology, Metabolism and Gerontology, Department of Medicine and Graduate Program in Immunology, Stanford University School of Medicine, Stanford, California 94305, USA
    Cell Metab 4:13-24. 2006
    ....
  9. ncbi Connecting type 1 and type 2 diabetes through innate immunity
    Justin I Odegaard
    Department of Pathology, Stanford University School of Medicine, Stanford, California 94305, USA
    Cold Spring Harb Perspect Med 2:a007724. 2012
    ..We conclude with a discussion of the therapeutic implications of this integrated understanding of diabetic pathology...